These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26667339)

  • 1. Immune Therapy.
    Lievense L; Aerts J; Hegmans J
    Adv Exp Med Biol; 2016; 893():59-90. PubMed ID: 26667339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune alterations and emerging immunotherapeutic approaches in lung cancer.
    Dasanu CA; Sethi N; Ahmed N
    Expert Opin Biol Ther; 2012 Jul; 12(7):923-37. PubMed ID: 22559147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune alterations in lung cancer - the new therapeutic approach].
    Domagała-Kulawik J; Osińska I
    Pneumonol Alergol Pol; 2014; 82(3):286-99. PubMed ID: 24793154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
    Spigel DR; Socinski MA
    J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy and lung cancer: current developments and novel targeted therapies.
    Domingues D; Turner A; Silva MD; Marques DS; Mellidez JC; Wannesson L; Mountzios G; de Mello RA
    Immunotherapy; 2014; 6(11):1221-35. PubMed ID: 25496336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for lung cancer: ongoing clinical trials.
    Declerck S; Vansteenkiste J
    Future Oncol; 2014 Jan; 10(1):91-105. PubMed ID: 24143916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome.
    Shepherd FA; Douillard JY; Blumenschein GR
    J Thorac Oncol; 2011 Oct; 6(10):1763-73. PubMed ID: 21876456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.
    Steendam CM; Dammeijer F; Aerts JGJV; Cornelissen R
    Immunotherapy; 2017 May; 9(6):507-520. PubMed ID: 28472903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Lung Cancer.
    Reinmuth N; Reck M
    Oncol Res Treat; 2016; 39(6):360-8. PubMed ID: 27259861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants.
    Gao F; You X; Yang L; Zou X; Sui B
    Int Rev Immunol; 2024; 43(5):280-308. PubMed ID: 38525925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for lung cancer: for whom the bell tolls?
    Madureira P; de Mello RA; de Vasconcelos A; Zhang Y
    Tumour Biol; 2015 Mar; 36(3):1411-22. PubMed ID: 25736929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological tumor therapy].
    Dietrich K; Theobald M
    Internist (Berl); 2015 Aug; 56(8):907-16; quiz 917. PubMed ID: 26187335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
    Anagnostou VK; Brahmer JR
    Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for pancreatic cancer: A long and hopeful journey.
    Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX
    Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.
    Chee J; Robinson BW; Holt RA; Creaney J
    Chest; 2017 Apr; 151(4):891-897. PubMed ID: 27769776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current immunotherapeutic strategies in lung cancer.
    Rüttinger D; Hatz RA; Jauch KW; Fox BA
    Surg Oncol Clin N Am; 2007 Oct; 16(4):901-18, x. PubMed ID: 18022551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitors.
    Aspeslagh S; Marabelle A; Soria JC; Armand JP
    Chin Clin Oncol; 2015 Dec; 4(4):48. PubMed ID: 26730760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy.
    Chan CW; Tsui SK; Law BM; So WK; Tang FW; Wong CL
    Int J Mol Sci; 2016 Feb; 17(3):286. PubMed ID: 26927069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.